Overview
- 8 FDA inspections are on record.
- 2 inspections produced a Form 483.
- The most recent recorded inspection date is 2024-10-04.
At a glance
Inspections
8
Form 483s
2
EIRs
0
Last outcome
Clean
Inspection history
FDA inspections on record, most recent first.
| Inspection | Category | Outcome | Form 483 |
|---|---|---|---|
| 30 Sep 2024 – 4 Oct 2024 | Human Drugs | Clean | |
| 9 Dec 2021 – 15 Dec 2021 | Human Drugs | Clean | |
| 11 Jun 2018 – 15 Jun 2018 | Human Drugs | 483 | View 483 → |
| 21 Feb 2018 – 28 Feb 2018 | Human Drugs | Clean | |
| 28 Nov 2017 – 4 Dec 2017 | Human Drugs | Clean | |
| 9 Feb 2015 – 21 Feb 2015 | Human Drugs | Clean | |
| 11 Mar 2013 – 15 Mar 2013 | Human Drugs | 483 | On file |
| 24 Sep 2009 | Not recorded | Clean |
Observations on record
Form 483 observations cited at this site, most recent first.
15 Jun 2018
21 CFR 314.80(b)
Failure to develop written procedures
Cited by Jennifer C Adams, Janete F Guardia
15 Jun 2018
21 CFR 314.80(c)(2)(ii)(B)
Late submission of an ICSR
Cited by Jennifer C Adams, Janete F Guardia
15 Jun 2018
21 CFR 314.80(c)(2)(ii)(B)
Periodic safety report missing ICSR
Cited by Jennifer C Adams, Janete F Guardia
Investigators
FDA investigators tied to this site in the record.
Kara A Scheibner1 insp.
Sylvestre K Dossou1 insp.
Geoffrey K Kilili1 insp.
Jennifer C Adams1 insp.
Janete F Guardia1 insp.
Susanne M Richardson1 insp.
Arindam Dasgupta1 insp.
Young M Choi1 insp.
Thea C Grome1 insp.
Timothy C Grome1 insp.
Paula J Bretz1 insp.
Jane M Kreis1 insp.
Recurring citations
CFR citation patterns observed across this site's inspections.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 314.80(c)(2)(ii)(B) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 314.80(b) | Cited across public-safe Form 483 observations | 1x |
Full site report
Get the verbatim findings behind Torrent Pharmaceuticals Limited's 2 Form 483s
Recurring CFR citations, so your team knows what this site gets cited for.
- The site's full inspection history, with every Form 483 and its outcome
- Warning letters and recalls tied to the company behind it
- Whether recurring CFR citations get closed out or repeat